Description
Dyrade M DS (Double Strength) is a robust combination medication formulated for the effective management of type 2 diabetes mellitus. It typically contains higher strengths of Gliclazide Modified Release and Metformin Hydrochloride, offering enhanced glycemic control for patients whose blood sugar is not adequately managed with lower doses or monotherapy. Gliclazide helps stimulate the pancreas to produce more insulin, especially after meals, while Metformin works to reduce glucose production in the liver and improve the body’s sensitivity to insulin. This powerful dual action significantly lowers elevated blood sugar levels, aiding in the prevention of diabetes-related complications and promoting better long-term health. Dyrade M DS is a key component of a comprehensive diabetes management plan that includes diet and exercise. This medication is strictly by prescription only.
